ClinicalTrials.gg
Not yet recruitingNCT07715019Updated Jul 20, 2026

Social Media Use and Motherhood

An observational study in Postpartum Period, sponsored by University of Salamanca. Not yet recruiting at 1 site in Spain. Open to female participants. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by University of Salamanca · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
85
Sex
Female
01

Study summary

This study aims to analyze the relationship between social media use, body image disorders, sexuality, sleep quality, and physical activity during the postpartum period. For this purpose, we will recruit 85 postpartum women through midwives from the Zamora Health Area. Following the signing of informed consent, participants will complete validated online questionnaires evaluating these dimensions. Participant recruitment and data collection will take place from September to December 2026.

02

Conditions studied

  • Postpartum Period

Keywords

  • Body Image
  • Sexuality
  • Physical activity
  • Postpartum period
  • Sleep quality
03

In context

Sexuality

130 studies on the registry are indexed under Sexuality; 26 are open to participants now.

This study's planned enrollment of 85 is below the median of 100 across 47 observational studies indexed under Sexuality.

Browse Sexuality studies →

Lead sponsor

University of Salamanca is the lead sponsor of 112 studies on the registry; 47 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women Within one year postpartum

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women Within one year postpartum

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
85 participants (estimated)
Target follow-up
4 Months
Patient registry
Yes

Groups and cohorts

  • Women in the Postpartum Period

    Within one year postpartum

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Body Image disorders

    Body Shape Questionnaire (BSQ-14) Measurement and Administration: The BSQ-14 is a self-reported, 14-item Likert-scale questionnaire. It measures the multi-dimensional construct of body image, specifically focusing on body shape dissatisfaction, fear of gaining weight, and self-deprecation due to physical appearance over the past four weeks. Scoring: Each item is rated on a 6-point scale ranging from 1 ("Never") to 6 ("Always"). Total scores are calculated by summing all items, yielding a range of 14 to 84, where higher scores reflect greater body shape dissatisfaction and distress. Definitions and Criteria: While the BSQ-14 is primarily used to evaluate the severity of body dissatisfaction along a continuum rather than as a diagnostic tool, established cutoff scores categorize the level of concern. Scores below 38 generally indicate no or mild concern, scores between 39 and 49 represent moderate concern, and scores of 50 or above indicate

    Time frame: Only at Baseline

Secondary outcomes

  1. Sleep quality

    Pittsburgh Sleep Quality Index (PSQI) Measurement and Administration: The PSQI is a 19-item self-reported questionnaire that assesses sleep quality and disturbances over a 1-month recall period. It measures seven clinical domains: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Scoring: Each of the seven component scores is rated from 0 (no difficulty) to 3 (severe difficulty). These component scores are summed to yield a single global score ranging from 0 to 21, with higher scores indicating poorer sleep quality. Definitions and Criteria: A global PSQI score greater than 5 is the established clinical cutoff used to distinguish "poor sleepers" from "good sleepers." This threshold yields high sensitivity and specificity in identifying significant sleep difficulties.

    Time frame: Only at Baseline

  2. Sexuality

    Female Sexual Function Index (FSFI) Measurement and Administration: The FSFI is a 19-item, self-reported questionnaire designed to assess key dimensions of female sexual function over the past 4 weeks. It measures six specific domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. Scoring: Individual items are scored on a Likert scale ranging from 0 or 1 to 5. The six domain scores are calculated by summing their respective items and multiplying by a specific factor weight. The final global score is obtained by adding the six weighted domain scores together, yielding a total score that ranges from 2.0 to 36.0, where lower scores indicate greater sexual dysfunction. Definitions and Criteria: A total global score of 26.55 or less is the widely accepted clinical cutoff point to classify individuals as being at risk for sexual dysfunction.

    Time frame: Only at Baseline

  3. Physical activity

    International Physical Activity Questionnaire (IPAQ-SF) Measurement and Administration: The IPAQ-SF is a 7-item self-reported questionnaire that assesses physical activity levels over the last 7 days. It measures the frequency (days per week) and duration (minutes per day) spent in three specific types of activity: walking, moderate-intensity activities, and vigorous-intensity activities, as well as daily sitting time. Scoring: Physical activity is quantified by converting the reported duration and frequency into Metabolic Equivalent of Task minutes per week (MET-minutes/week). Standard MET values are assigned to each activity type (3.3 for walking, 4.0 for moderate activity, and 8.0 for vigorous activity) to calculate a total weekly physical activity score. Definitions and Criteria: Based on the calculated MET-minutes/week and frequency of activities, participants are classified into three categorical levels of physical activity: Low, moderate, high

    Time frame: Only at Baseline

07

Study locations

1 site
  • Jose Ignacio Recio
    Zamora, Zamora, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2026
First posted
Jul 20, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Mar 30, 2027
Last update
Jul 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07715019
Responsible party
José Ignacio Recio Rodriguez (Professor, University of Salamanca) — Principal investigator
First posted
Jul 20, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Mar 30, 2027 (estimated)
Last update
Jul 20, 2026

Study contacts

JOSE I RECIO RODRIGUEZ, PhD
Contact
donrecio@usal.es
650330694

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion